News & Media
Find recent and archived news, press releases, and stories here.

Feb 15, 2022

Neurocentria obtains FDA Approval to Conduct Pivotal Phase IIb/III Clinical Trial for Testing Safety and Efficacy of Drug Candidate NRCT-101SR in Adults with ADHD

Jul 30, 2018

+

 Neurocentria launches phase 2 trial in stage 2 AD patients focusing on cognition, mood, and sleep (NC010)

Apr 6, 2018

Neurocentria Launches Phase 2b Clinical Trial Testing the Efficacy of MMFS in Stage 3 and 4 Alzheimer’s Disease Patients (NC007b)

Mar 3, 2018

Neurocentria Announces Completion and Positive Top-Line Results of MMFS Trial in Adult ADHD  

Jul 13, 2017

Neurocentria to Present New Data on MMFS in Mild-Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2017

Oct 28, 2015

Neurocentria Publishes Article Demonstrating its Candidate Compound MMFS can Improve Brain Age by 9 Years in Older Adults with Mild Cognitive Impairment 

Jul 13, 2015

 Neurocentria Presents Results of Phase 2 Clinical Study of MMFS in Elderly with Mild Cognitive Impairment at Alzheimer’s Association International Conference (AAIC) 2015 

Sep 13, 2014 

Neurocentria Demonstrates that Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 

Feb 2, 2010

Science Daily: Magnesium Supplement helps boost brain power

Jan 27, 2010

WebMD: Magnesium may improve memory 

Dec 1, 2004

MIT News: Magnesium may reverse middle-age memory loss